+Compare
ABCM
Stock ticker:
NASDAQ
AS OF
Jun 29, 01:05 PM (EDT)
Price
$14.41
Change
-$0.15 (-1.03%)
Capitalization
3.39B

ABCM Price Prediction, Abcam plc AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jun 28, 2022

Momentum Indicator for ABCM turns positive, indicating new upward trend

ABCM saw its Momentum Indicator move above the 0 level on June 24, 2022. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator turned positive. In 22 of the 32 cases, the stock moved higher in the following days. The odds of a move higher are at 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ABCM just turned positive on June 22, 2022. Looking at past instances where ABCM's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABCM advanced for three days, in of 87 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 74 cases where ABCM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

ABCM moved below its 50-day moving average on June 28, 2022 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABCM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ABCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.137) is normal, around the industry mean (24.911). P/E Ratio (178.571) is within average values for comparable stocks, (95.185). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.885). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (8.985) is also within normal values, averaging (297.261).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Global Blood Therapeutics (NASDAQ:GBT), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.74B. The market cap for tickers in the group ranges from 2.5K to 255.71B. NONOF holds the highest valuation in this group at 255.71B. The lowest valued company is IMUND at 2.5K.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was -36%. EVFM experienced the highest price growth at 233%, while IVBT experienced the biggest fall at -86%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 4%. For the same stocks of the Industry, the average monthly volume growth was 30% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 63
SMR Rating: 94
Profit Risk Rating: 94
Seasonality Score: 0 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Discovery Drive
Phone
+44 1223696000
Employees
1682
Web
https://www.abcam.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDHY14.80-0.08
-0.54%
PGIM Short Duration High Yield Opportunities Fund
IDME20.23-0.13
-0.64%
International Drawdown Managed Eq ETF
FEBZ25.97-0.32
-1.21%
TrueShares Structured OutcomeFebruaryETF
FDRV18.67-0.44
-2.30%
Fidelity® Elctrc Vhcls & Ftr Trnsptn ETF
XLG288.99-7.36
-2.48%
Invesco S&P 500® Top 50 ETF

ABCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCM has been loosely correlated with CDXS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCM jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCM
1D Price
Change %
ABCM100%
-2.80%
CDXS - ABCM
50%
Loosely correlated
-0.89%
AVXL - ABCM
45%
Loosely correlated
-1.78%
TECH - ABCM
44%
Loosely correlated
-2.07%
CRSP - ABCM
44%
Loosely correlated
-5.41%
ADPT - ABCM
44%
Loosely correlated
-4.19%
More